C-peptide: a new mediator of atherosclerosis in diabetes

C-peptide: a new mediator of atherosclerosis in diabetes

Item
http://www.wikidata.org/entity/Q38006686
Comprehensive biomarker testing of glycemia, insulin resistance, and beta cell function has greater sensitivity to detect diabetes risk than fasting glucose and HbA1c and is associated with improved glycemic control in clinical practiceAssociation of insulin-related serum factors with colorectal polyp number and type in adult males.The clinical measures associated with C-peptide decline in patients with type 1 diabetes over 15 years.Synergistic effects of C-peptide and insulin on low O2-induced ATP release from human erythrocytes.Examining the role of insulin in the regulation of cardiovascular health.High levels of iron status and oxidative stress in patients with metabolic syndrome.A 9-Month Toxicity and Toxicokinetic Assessment of Subcutaneous Pegylated Human C-peptide (CBX129801) in Cynomolgus Monkeys.
P2860

C-peptide: a new mediator of atherosclerosis in diabetes

Item
http://www.wikidata.org/entity/Q38006686
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
C-peptide: a new mediator of atherosclerosis in diabetes
@en
type
label
C-peptide: a new mediator of atherosclerosis in diabetes
@en
prefLabel
C-peptide: a new mediator of atherosclerosis in diabetes
@en
P1433
P1476
P2093
P275
P2860
P304
P31
P356
P478
P5008
P577
P5875
P698
P921
P932
P356
P1433
P1476
C-peptide: a new mediator of atherosclerosis in diabetes
@en
P2093
P275
P2860
P304
P31
P356
P478
P5008
P577
P5875
P698
P921
P932